<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04629911</url>
  </required_header>
  <id_info>
    <org_study_id>MED-DE1-20-424</org_study_id>
    <nct_id>NCT04629911</nct_id>
  </id_info>
  <brief_title>High Flow Nasal Oxygenation and Gastric Insufflation in Anesthetized Patients</brief_title>
  <official_title>The Effect of High Flow Nasal Oxygenation on Gastric Insufflation in Paralyzed Anesthetized Patients Undergoing Laryngologic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ajou University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ajou University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Transnasal humidified rapid-insufflation ventilatory exchange(THRIVE), or also termed high&#xD;
      flow nasal oxygenation (HFNO) is a method of supplying heated, humidified high concentrations&#xD;
      of oxygen via nasal cavity.&#xD;
&#xD;
      The purpose of this study is to investigate the effect of HFNO on gastric insufflation in&#xD;
      paralyzed anesthetized patients undergoing laryngologic surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      HFNO can be used during intraoperative period. HFNO reduces the risk of desaturation and&#xD;
      prolongs the safe apnea time, compared with conventional oxygenation.&#xD;
&#xD;
      In laryngeal microsurgery, HFNO therapy make possible to perform tubeless anesthesia,&#xD;
      providing perfect exposure of structure of the vocal cords.&#xD;
&#xD;
      HFNO have a risk for low level of positive pressure can make gastric distension, but gastric&#xD;
      reflux or aspiration were not occurred during rapid sequence induction for emergency&#xD;
      operation.&#xD;
&#xD;
      The purpose of this study is to investigate the effect of HFNO on gastric insufflation in&#xD;
      paralyzed anesthetized patients undergoing laryngologic surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 23, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change of gastric volume</measure>
    <time_frame>before HFNO application (baseline), immediately after HFNO application</time_frame>
    <description>Ultrasound exam will measure the antral cross-sectional area of gastric antrum</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Gastric Distention</condition>
  <arm_group>
    <arm_group_label>HFNO arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive HFNO therapy during laryngomicrosurgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>THRIVE</intervention_name>
    <description>Patients will receive HFNO therapy during laryngomicrosurgery. Patients will undergo a gastric ultrasound examination after HFNO therapy.</description>
    <arm_group_label>HFNO arm</arm_group_label>
    <other_name>Optiflow</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  American Society of Anesthesiology physical status classification I and II&#xD;
&#xD;
          -  Patients scheduled for laryngeal microsurgery under general anesthesia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  gastroesophageal reflux&#xD;
&#xD;
          -  gastric pathology&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  major cardiovascular, pulmonary, or cerebrovascular disease&#xD;
&#xD;
          -  severe obesity (body mass index&gt;35 kg/m2)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jong Yeop Kim</last_name>
    <phone>+82312195574</phone>
    <email>kjyeop@ajou.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ajou University Hospital</name>
      <address>
        <city>Suwon</city>
        <state>Gyeongki-do</state>
        <zip>443-721</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jong Yeop Kim, M.D., Ph.D.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>November 10, 2020</study_first_submitted>
  <study_first_submitted_qc>November 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 16, 2020</study_first_posted>
  <last_update_submitted>December 29, 2020</last_update_submitted>
  <last_update_submitted_qc>December 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ajou University School of Medicine</investigator_affiliation>
    <investigator_full_name>Jong Yeop Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dilatation, Pathologic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

